The sweetened offer comes days after Advent improved its bid for Spectris, prompting the target to withdraw its ...

LONDON (Reuters) -British scientific instruments maker Spectris has agreed to a sweetened offer from U.S. private equity firm ...

The choice filling process begins at 4 pm on August 7 and end on August 8, 2025. The round 2 allotment result will be ...

Macquarie Group Ltd. is set to buy a minority stake in Portuguese hospital operator Luz Saude SA, outbidding rivals CVC ...

US private equity group’s offer nudges out rival bidder once again in race to acquire UK scientific instruments maker ...

KKR ups its bid for Spectris to £4.2 billion, overtaking Advent in a fierce takeover race for the UK scientific instruments ...

Henry Schein's Q2 2025 earnings highlight global sales growth, cost-saving initiatives, margin strategies, and leadership transition plans.

Private equity giant KKR has trumped rival Advent's takeover bid for British scientific instruments maker Spectris with an ...

The private equity bidding war for precision instrument business Spectris has stepped up a gear after KKR submitted a fresh ...

KKR has agreed on a recommended increased cash offer for Spectris at an offer value of £41.75 per share. This values the entire issued and to be issued share capital of Spectris at around £4.2 billion ...

Strong demand is fuelling credit markets, but KKR warns the rally won’t last forever. Here’s how they're balancing risk and opportunity.

The increased offer from KKR, which will be implemented through a court-sanctioned scheme of arrangement, represents a substantial premium of 104.9% to Spectris’ closing price of £20.38 on June 6, ...